John G. Cumming

1.2k total citations
30 papers, 881 citations indexed

About

John G. Cumming is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, John G. Cumming has authored 30 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 13 papers in Molecular Biology and 7 papers in Computational Theory and Mathematics. Recurrent topics in John G. Cumming's work include Synthetic Organic Chemistry Methods (9 papers), Computational Drug Discovery Methods (7 papers) and Traditional and Medicinal Uses of Annonaceae (7 papers). John G. Cumming is often cited by papers focused on Synthetic Organic Chemistry Methods (9 papers), Computational Drug Discovery Methods (7 papers) and Traditional and Medicinal Uses of Annonaceae (7 papers). John G. Cumming collaborates with scholars based in United Kingdom, Sweden and Switzerland. John G. Cumming's co-authors include Ian Paterson, Richard A. Ward, A. M. Davis, Hongming Chen, Sorel Mureşan, Markus Haeberlein, Julian D. Smith, Kap‐Sun Yeung, Jonathan Clayden and Catherine McCarthy and has published in prestigious journals such as Journal of the American Chemical Society, Nature Reviews Drug Discovery and Journal of Medicinal Chemistry.

In The Last Decade

John G. Cumming

29 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John G. Cumming United Kingdom	17	500	295	222	114	87	30	881
Alexander G. Dossetter United Kingdom	17	627 1.3×	219 0.7×	169 0.8×	87 0.8×	87 1.0×	24	886
David S. Millan United Kingdom	13	352 0.7×	287 1.0×	104 0.5×	61 0.5×	52 0.6×	23	681
Nigel G. Ramsden United Kingdom	19	1.1k 2.2×	942 3.2×	164 0.7×	110 1.0×	126 1.4×	25	1.5k
Martin P. Edwards United States	15	492 1.0×	518 1.8×	286 1.3×	29 0.3×	149 1.7×	30	1.2k
Kenneth A. Savin United States	14	657 1.3×	353 1.2×	137 0.6×	71 0.6×	143 1.6×	18	1.1k
Hugo Lachance Canada	13	639 1.3×	375 1.3×	64 0.3×	52 0.5×	134 1.5×	17	930
Ted W. Johnson United States	18	395 0.8×	790 2.7×	214 1.0×	55 0.5×	93 1.1×	28	1.6k
Éric Therrien Canada	21	411 0.8×	649 2.2×	237 1.1×	27 0.2×	98 1.1×	34	1.1k
C. John Blankley United States	17	510 1.0×	419 1.4×	123 0.6×	41 0.4×	90 1.0×	33	1.0k
Roger B. Ruggeri United States	24	1.1k 2.2×	815 2.8×	134 0.6×	68 0.6×	126 1.4×	43	2.2k

Countries citing papers authored by John G. Cumming

Since Specialization

Citations

This map shows the geographic impact of John G. Cumming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Cumming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Cumming more than expected).

Fields of papers citing papers by John G. Cumming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Cumming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Cumming. The network helps show where John G. Cumming may publish in the future.

Co-authorship network of co-authors of John G. Cumming

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Cumming. A scholar is included among the top collaborators of John G. Cumming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Cumming. John G. Cumming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cumming, John G., Lukas M. Kreis, Maarten Vercruysse, et al.. (2023). Novel Indane-Containing NBTIs with Potent Anti-Gram-Negative Activity and Minimal hERG Inhibition. ACS Medicinal Chemistry Letters. 14(12). 1791–1799. 1 indexed citations

Cumming, John G., M. Raymond V. Finlay, Fabrizio Giordanetto, et al.. (2014). Potential Strategies for Increasing Drug-Discovery Productivity. Future Medicinal Chemistry. 6(5). 515–527. 16 indexed citations

Cumming, John G., J.E. Debreczeni, Fredrik Edfeldt, et al.. (2014). Discovery and Characterization of MAPK-activated Protein Kinase-2 Prevention of Activation Inhibitors. Journal of Medicinal Chemistry. 58(1). 278–293. 7 indexed citations

Cumming, John G., A. M. Davis, Sorel Mureşan, Markus Haeberlein, & Hongming Chen. (2013). Chemical predictive modelling to improve compound quality. Nature Reviews Drug Discovery. 12(12). 948–962. 213 indexed citations

Cumming, John G., Jon Winter, & Andrew R. Poirrette. (2012). Better compounds faster: the development and exploitation of a desktop predictive chemistry toolkit. Drug Discovery Today. 17(17-18). 923–927. 6 indexed citations

Cumming, John G., Justin Bower, David Waterson, et al.. (2012). The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity. Bioorganic & Medicinal Chemistry Letters. 22(12). 3895–3899. 16 indexed citations

Cumming, John G., Howard Tucker, J.W. Oldfield, et al.. (2012). Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. Bioorganic & Medicinal Chemistry Letters. 22(4). 1655–1659. 21 indexed citations

Brown, Dearg S., John G. Cumming, Paul A. Bethel, et al.. (2012). The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 22(12). 3879–3883. 9 indexed citations

Savi, Chris De, Andrew R. Pape, John G. Cumming, et al.. (2011). Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry Letters. 21(11). 3301–3306. 13 indexed citations

10.

Wood, David, et al.. (2011). Automated QSAR with a Hierarchy of Global and Local Models. Molecular Informatics. 30(11-12). 960–972. 32 indexed citations

11.

Savi, Chris De, Andrew R. Pape, John G. Cumming, et al.. (2011). The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry Letters. 21(5). 1376–1381. 18 indexed citations

12.

Cumming, John G., S Brown, Anne Cooper, et al.. (2006). Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides. Bioorganic & Medicinal Chemistry Letters. 16(13). 3533–3536. 15 indexed citations

13.

Cumming, John G., Anne Cooper, Ken Grime, et al.. (2005). Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides. Bioorganic & Medicinal Chemistry Letters. 15(22). 5012–5015. 21 indexed citations

14.

Cumming, John G., et al.. (2004). Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 14(21). 5389–5394. 54 indexed citations

15.

Clayden, Jonathan, Catherine McCarthy, & John G. Cumming. (1998). (S)-2-(Dibenzylamino)-3-phenylpropanal as a chiral auxiliary: a new strategy for the asymmetric synthesis of 2-substituted alcohols. Tetrahedron Asymmetry. 9(8). 1427–1440. 15 indexed citations

16.

Paterson, Ian, Kap‐Sun Yeung, Richard A. Ward, John G. Cumming, & Julian D. Smith. (1994). Total Synthesis of Swinholide A and Hemiswinholide A. Journal of the American Chemical Society. 116(20). 9391–9392. 55 indexed citations

17.

Paterson, Ian, John G. Cumming, Julian D. Smith, & Richard A. Ward. (1994). Studies in marine macrolide synthesis: Boron and silicon-mediated coupling strategies for Swinholide A. Tetrahedron Letters. 35(3). 441–444. 43 indexed citations

18.

Paterson, Ian, John G. Cumming, Julian D. Smith, Richard A. Ward, & Kap‐Sun Yeung. (1994). Towards the synthesis of swinholide A and scytophycin C. A highly stereocontrolled synthesis of (−)-pre-swinholide A. Tetrahedron Letters. 35(20). 3405–3408. 25 indexed citations

19.

Paterson, Ian, Julian D. Smith, Richard A. Ward, & John G. Cumming. (1994). Total Synthesis of (-)-Preswinholide A. Journal of the American Chemical Society. 116(6). 2615–2616. 29 indexed citations

20.

Paterson, Ian & John G. Cumming. (1992). A stereocontrolled synthesis of a C19-C32 / C17-C30 Segment for swinholide A and misakinolide A, Cytotoxic dimeric macrolides from theonella swinhoei.. Tetrahedron Letters. 33(20). 2847–2850. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact